Why ZNTL? Zentalis Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
ZNTL
$4.09+0.08 (+2.00%)
Market ClosedLast close May 1
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.